Renalytix Management
Management criteria checks 3/4
Renalytix's CEO is James McCullough, appointed in Mar 2018, has a tenure of 6.67 years. total yearly compensation is $780.11K, comprised of 65.3% salary and 34.7% bonuses, including company stock and options. directly owns 0.058% of the company’s shares, worth $18.65K. The average tenure of the management team and the board of directors is 3.6 years and 1.3 years respectively.
Key information
James McCullough
Chief executive officer
US$780.1k
Total compensation
CEO salary percentage | 65.3% |
CEO tenure | 6.7yrs |
CEO ownership | 0.06% |
Management average tenure | 3.6yrs |
Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Renalytix: The Investment Case Is Shot
Jul 25Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M
Jun 30Renalytix: High Growth Artificial Intelligence Play, Nearing A Possible Breakout
Apr 05Renalytix: Laying The Foundations For Growth
Jan 05Renalytix: Building Out A Capability To Ramp Revenue
Oct 20Renalytix AI EPS beats by $0.06, misses on revenue
Jun 15CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$28m |
Jun 30 2024 | US$780k | US$510k | -US$33m |
Mar 31 2024 | n/a | n/a | -US$37m |
Dec 31 2023 | n/a | n/a | -US$42m |
Sep 30 2023 | n/a | n/a | -US$44m |
Jun 30 2023 | US$1m | US$601k | -US$46m |
Mar 31 2023 | n/a | n/a | -US$40m |
Dec 31 2022 | n/a | n/a | -US$42m |
Sep 30 2022 | n/a | n/a | -US$47m |
Jun 30 2022 | US$636k | US$601k | -US$45m |
Mar 31 2022 | n/a | n/a | -US$50m |
Dec 31 2021 | n/a | n/a | -US$44m |
Sep 30 2021 | n/a | n/a | -US$38m |
Jun 30 2021 | US$1m | US$586k | -US$35m |
Mar 31 2021 | n/a | n/a | -US$28m |
Dec 31 2020 | n/a | n/a | -US$20m |
Sep 30 2020 | n/a | n/a | -US$16m |
Jun 30 2020 | US$488k | US$470k | -US$10m |
Mar 31 2020 | n/a | n/a | US$28m |
Dec 31 2019 | n/a | n/a | -US$8m |
Sep 30 2019 | n/a | n/a | -US$5m |
Jun 30 2019 | US$216k | US$269k | -US$42m |
Compensation vs Market: James's total compensation ($USD780.11K) is about average for companies of similar size in the US market ($USD649.07K).
Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.
CEO
James McCullough (56 yo)
6.7yrs
Tenure
US$780,110
Compensation
Mr. James R. McCullough served as Independent Non-Executive Director of LungLife AI, Inc. from July 08, 2021 to October 24, 2024. Mr. McCullough is CEO of Renalytix Plc.and served as Chairman Mr. McCulloug...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer & Director | 6.7yrs | US$780.11k | 0.058% $ 18.6k | |
CTO & Executive Director | 6.7yrs | US$425.70k | 0.17% $ 55.3k | |
Chief Medical Officer | 6.7yrs | US$380.01k | 0% $ 0 | |
Executive Chairman | less than a year | US$14.89k | no data | |
President | less than a year | no data | no data | |
Interim CFO & Principal Accounting Officer | less than a year | no data | no data | |
Company Secretary | no data | no data | no data |
3.6yrs
Average Tenure
61.5yo
Average Age
Experienced Management: RNLX.Y's management team is considered experienced (3.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer & Director | no data | US$780.11k | 0.058% $ 18.6k | |
CTO & Executive Director | 6.7yrs | US$425.70k | 0.17% $ 55.3k | |
Executive Chairman | less than a year | US$14.89k | no data | |
Independent Non-Executive Director | 6yrs | no data | no data | |
Independent Non-Executive Director | 6.7yrs | no data | 0% $ 0 | |
Member of Clinical Advisory Board | 1.3yrs | no data | no data | |
Member of Clinical Advisory Board | 1.3yrs | no data | no data | |
Member of Clinical Advisory Board | 1.3yrs | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | 5.3yrs | no data | no data | |
Independent Non-Executive Director | 1.4yrs | US$68.15k | 0% $ 0 | |
Member of Clinical Advisory Board | 1.3yrs | no data | no data |
1.3yrs
Average Tenure
57.5yo
Average Age
Experienced Board: RNLX.Y's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.